Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Open Access
Abstract
Liquid biopsies are increasingly used for the diagnosis and follow-up of cancer patients. Urine is a body fluid that can be used to detect cancers and others diseases. It is noninvasive and easy to collect. To detect Bladder Cancer (BC), cytology is the first assay used. It is an effective way to detect high grade BC but has a high rate of equivocal results, especially for low grade BC. Furthermore, cystoscopy is used to confirm cytology results and to determine cancer status. Cystoscopy is also effective but highly invasive, and not well accepted by patients, especially for BC follow-up. In this review we survey the numerous assays recently developed in order to diagnose BC at an early stage, and to facilitate the follow-up of patients. We discuss their effectiveness, ease of use, and applications. Finally, we discuss assays that, in the future, could improve the diagnosis and management of BC patients.Keywords
This publication has 131 references indexed in Scilit:
- Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 HypermethylationPLOS ONE, 2012
- Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human BladderAdvances in Urology, 2012
- Urine Collection and Processing for Protein Biomarker Discovery and QuantificationCancer Epidemiology, Biomarkers & Prevention, 2010
- HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder CancerEuropean Urology, 2010
- Quantitation of Aurora Kinase A Gene Copy Number in Urine Sediments and Bladder Cancer DetectionJNCI: Journal of the National Cancer Institute, 2008
- Development of a Multiplex RNA Urine Test for the Detection and Stratification of Transitional Cell Carcinoma of the BladderClinical Cancer Research, 2008
- The expression and significance of survivin mRNA in urinary bladder carcinomasJournal of Cancer Research and Clinical Oncology, 2004
- Tumor-Derived HyaluronidaseJournal of Urology, 1998
- MAUB Is a New Mucin Antigen Associated with Bladder CancerJournal of Biological Chemistry, 1996
- A ‘New’ Human Blood Group Antigen of Frequent OccurrenceNature, 1946